These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19116690)

  • 1. Lentiviral vector-derived shRNAs confer enhanced suppression of Semliki forest virus replication in BHK-21 cells compared to shRNAs expressed from plasmids.
    Zhang K; Chen Y; Pan J; Ahola T; Guo D
    Biotechnol Lett; 2009 Apr; 31(4):501-8. PubMed ID: 19116690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated inhibition of Semliki Forest virus replication in mammalian cells.
    Seyhan AA; Alizadeh BN; Lundstrom K; Johnston BH
    Oligonucleotides; 2007; 17(4):473-84. PubMed ID: 18095875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective inhibition of Japanese encephalitis virus replication by small interfering RNAs targeting the NS5 gene.
    Qi WB; Hua RH; Yan LP; Tong GZ; Zhang GH; Ren T; Wu DL; Liao M
    Virus Res; 2008 Mar; 132(1-2):145-51. PubMed ID: 18190994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A luciferase-based screening method for inhibitors of alphavirus replication applied to nucleoside analogues.
    Pohjala L; Barai V; Azhayev A; Lapinjoki S; Ahola T
    Antiviral Res; 2008 Jun; 78(3):215-22. PubMed ID: 18294708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell specificity and efficiency of the Semliki forest virus vector- and adenovirus vector-mediated gene expression in mouse cerebellum.
    Sato Y; Shiraishi Y; Furuichi T
    J Neurosci Methods; 2004 Aug; 137(1):111-21. PubMed ID: 15196833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
    Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
    Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Hepatitis E virus replication using short hairpin RNA (shRNA).
    Kumar A; Panda SK; Durgapal H; Acharya SK; Rehman S; Kar UK
    Antiviral Res; 2010 Mar; 85(3):541-50. PubMed ID: 20105445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mammalian membrane proteins in mammalian cells using Semliki Forest virus vectors.
    Lundstrom K
    Methods Mol Biol; 2010; 601():149-63. PubMed ID: 20099145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of viral hemorrhagic septicemia virus replication using a short hairpin RNA targeting the G gene.
    Kim MS; Kim KH
    Arch Virol; 2011 Mar; 156(3):457-64. PubMed ID: 21184243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
    Kim JY; Chung SK; Hwang HY; Kim H; Kim JH; Nam JH; Park SI
    Virus Res; 2007 Apr; 125(1):9-13. PubMed ID: 17222937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
    von Eije KJ; ter Brake O; Berkhout B
    J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative RT-PCR for titration of replication-defective recombinant Semliki Forest virus.
    Puglia AL; Rezende AG; Jorge SA; Wagner R; Pereira CA; Astray RM
    J Virol Methods; 2013 Nov; 193(2):647-52. PubMed ID: 23933080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability.
    Casales E; Rodriguez-Madoz JR; Ruiz-Guillen M; Razquin N; Cuevas Y; Prieto J; Smerdou C
    Virology; 2008 Jun; 376(1):242-51. PubMed ID: 18442838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo.
    Feng Z; Jiang P; Wang X; Li Y; Jiang W
    Antiviral Res; 2008 Mar; 77(3):186-94. PubMed ID: 18199493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice.
    Sonwane AA; Dahiya SS; Saini M; Chaturvedi VK; Singh RP; Gupta PK
    Res Vet Sci; 2012 Aug; 93(1):498-503. PubMed ID: 21767857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific small interfering RNAs-mediated inhibition of replication of porcine encephalomyocarditis virus in BHK-21 cells.
    Jia H; Ge X; Guo X; Yang H; Yu K; Chen Z; Chen Y; Cha Z
    Antiviral Res; 2008 Aug; 79(2):95-104. PubMed ID: 18243347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.